Aplastic anemia (Q81025689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Aplastic anemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Rodrigo T. Calado

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Neal S Young

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Hematology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

162-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

Progressive telomere shortening in aplastic anemia

5 January 2020

cites work

1 reference

12 December 2020

Long-term outcome after marrow transplantation for severe aplastic anemia

1 reference

12 December 2020

Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group

1 reference

12 December 2020

Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (E

1 reference

12 December 2020

X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene

1 reference

12 December 2020

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy

1 reference

12 December 2020

Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.

1 reference

12 December 2020

Paroxysmal nocturnal hemoglobinuria: current issues in pathophysiology and treatment

1 reference

12 December 2020

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia

1 reference

12 December 2020

Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia

1 reference

12 December 2020

Incidence of aplastic anemia and agranulocytosis in Latin America: the LATIN study

1 reference

12 December 2020

Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome

1 reference

12 December 2020

Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients.

1 reference

12 December 2020

Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival

1 reference

12 December 2020

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

1 reference

12 December 2020

The epidemiology of aplastic anemia in Thailand

1 reference

12 December 2020

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience

1 reference

12 December 2020

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

1 reference

12 December 2020

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation

1 reference

12 December 2020

T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia

1 reference

12 December 2020

Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil

1 reference

12 December 2020

Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia

1 reference

12 December 2020

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

1 reference

12 December 2020

Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor

1 reference

12 December 2020

Current concepts in the pathophysiology and treatment of aplastic anemia

1 reference

12 December 2020

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

1 reference

12 December 2020

CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins

1 reference

12 December 2020

Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells

1 reference

12 December 2020

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

1 reference

12 December 2020

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

1 reference

12 December 2020

Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

12 December 2020

1 reference

12 December 2020

Cytokine gene polymorphisms in acquired bone marrow failure

1 reference

12 December 2020

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

1 reference

12 December 2020

Mutations in the SBDS gene in acquired aplastic anemia

1 reference

12 December 2020

Red blood cell transfusion in clinical practice

1 reference

12 December 2020

Platelet transfusions

1 reference

12 December 2020

Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.

1 reference

12 December 2020

Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan

1 reference

12 December 2020

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

1 reference

12 December 2020

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

1 reference

12 December 2020

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

1 reference

12 December 2020

Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapiant

1 reference

12 December 2020

Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia

1 reference

12 December 2020

Current status of allogeneic bone marrow transplantation in acquired aplastic anemia

1 reference

12 December 2020

Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine

1 reference

12 December 2020

Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on

1 reference

12 December 2020

Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia

1 reference

12 December 2020

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial

1 reference

12 December 2020

Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.

1 reference

12 December 2020

Telomere length in leukocyte subpopulations of patients with aplastic anemia

1 reference

12 December 2020

The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita

1 reference

12 December 2020

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

1 reference

12 December 2020

Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.

1 reference

12 December 2020

Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children

1 reference

12 December 2020

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

1 reference

12 December 2020

Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia

1 reference

12 December 2020

Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia

1 reference

12 December 2020

Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia

1 reference

12 December 2020

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

1 reference

12 December 2020

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

1 reference

12 December 2020

Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia

1 reference

12 December 2020

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA

1 reference

12 December 2020

Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes

1 reference

12 December 2020

Evolution of clonal cytogenetic abnormalities in aplastic anemia

1 reference

12 December 2020

Analysis of T-cell repertoire in hepatitis-associated aplastic anemia

1 reference

12 December 2020

In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing

1 reference

12 December 2020

Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population

1 reference

12 December 2020

Natural history of moderate aplastic anemia in children

1 reference

12 December 2020

Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.

1 reference

12 December 2020

Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies

1 reference

12 December 2020

Biological and immunological characterization of ATG and ALG

1 reference

12 December 2020

Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group

1 reference

12 December 2020

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

1 reference

12 December 2020

Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia

1 reference

12 December 2020

Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry

1 reference

12 December 2020

Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia

1 reference

12 December 2020

Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance

1 reference

12 December 2020

Increased apoptotic cells in bone marrow biopsies from patients with aplastic anaemia

1 reference

12 December 2020

Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia

1 reference

12 December 2020

10.1097/MOH.0B013E3282FA7470

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18391779%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

18391779

1 reference